The role of nuclear medicine in the management of thymomas.

AIM OF THE STUDY To evaluate the role of nuclear medicine techniques in the management of patients with thymoma. MATERIALS AND METHODS The Authors performed a review of the literature about the usefulness of traditional nuclear medicine and positron emission tomography in patients with thymic tumours. RESULTS AND DISCUSSION Nuclear medicine imaging can provide additional information in cases of thymoma such as in differential diagnosis between thymic tumours, staging and restaging. Thallium-201 (201Tl), 99mTc-sestamibi and 99mTc-tetrofosmin are useful tumour-imaging agent. Another radiopharmaceutical useful in the management of thymomas is 111In-pentetreotide, a somatostatin analogue, used to define the receptor status and the extent of disease in malignant thymomas. Positron emission tomography (PET) is a powerful diagnostic tool for diagnosis, staging and restaging of neoplasms in general. The most used PET radiopharmaceutical is the fluorodeoxyglucose (18F-FDG), a glucose analogue. The uptake of FDG reflects the metabolic activity of organs and neoplasms and correlates with the tumour growth rate. There is a paucity of literature on the use of PET scanning in the diagnosis of thymoma. Further perspective studies with a larger number of cases, considering the development of hybrid imaging PET-CT and new PET radiopharmaceuticals, may increase the role of nuclear medicine in the diagnostic and therapeutic management of thymic neoplasms.

[1]  S. Bagga,et al.  Imaging of an Invasive Malignant Thymoma on PET Scan: CT and Histopathologic Correlation , 2006, Clinical nuclear medicine.

[2]  J. Choi,et al.  18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  O. Kocher,et al.  The thymus: a comprehensive review. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.

[4]  T. Naruke,et al.  Positive imaging of thymoma by 11C-acetate positron emission tomography. , 2006, The Annals of thoracic surgery.

[5]  Ren-Shyan Liu,et al.  Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: A preliminary report , 1995, European Journal of Nuclear Medicine.

[6]  E. Kramer,et al.  Spectrum of thymic uptake at 18F-FDG PET. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

[7]  L. Cinotti,et al.  FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. , 2004, Brain : a journal of neurology.

[8]  J. Fletcher,et al.  Thymoma and myotonic dystrophy: successful treatment with chemotherapy and radiation: case report and review of the literature. , 2002, Chest.

[9]  Y. K. Kim,et al.  Tc-99m MIBI, Tc-99m Tetrofosmin, and Tc-99m (V) DMSA Accumulation in Recurrent Malignant Thymoma , 2002, Clinical nuclear medicine.

[10]  O. Matsui,et al.  Thymic lesions in patients with myasthenia gravis: characterization with thallium 201 scintigraphy. , 2001, Radiology.

[11]  S. Lamberts,et al.  Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro. , 2000, The Journal of clinical endocrinology and metabolism.

[12]  M. Sasaki,et al.  Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  D. Ettinger,et al.  Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma. , 1999, Clinical nuclear medicine.

[14]  M. Salvatore,et al.  In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  M. Nakade,et al.  Tl-201 and Tc-99m HMPAO SPECT in a patient with recurrent thymoma. , 1996, Clinical nuclear medicine.

[16]  H. Fukuda,et al.  PET imaging of primary mediastinal tumours. , 1996, British Journal of Cancer.